DTAN - ETF AI Analysis
Top Page
Sparkline International Intangible Value ETF (DTAN)
Rating:66Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, including Japan, Germany, the U.S., and several others, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across areas like consumer, health care, technology, and industrials, so the ETF is not overly tied to the fortunes of just one industry.
Several Strong Top Holdings
Some of the largest positions, such as Novartis, AstraZeneca, Shell, and Siemens Energy, have shown strong recent performance, supporting the fund’s overall returns.
Negative Factors
Moderately High Expense Ratio
The fund’s fee is on the higher side for an ETF, which can slowly eat into long-term returns compared with lower-cost options.
Small Asset Base
With relatively low assets under management, the ETF may be less liquid and more vulnerable to investor inflows and outflows than larger funds.
Mixed Performance Among Top Holdings
Several major positions, including Roche, Toyota, L’Oreal, and Sanofi, have shown weaker recent performance, which can drag on the fund’s results.
DTAN vs. SPDR S&P 500 ETF (SPY)
AUM20.75M
RegionGlobal Ex-U.S.
Expense Ratio0.55%
Beta0.81
IssuerSparkline
Inception DateSep 09, 2024
Dividend Yield1.69%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,617
30 Day Avg. Volume3,014
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
37.32Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering126
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DTAN Summary
The Sparkline International Intangible Value ETF (DTAN) invests in companies around the world that are strong in “intangible” assets like brands, patents, and research, rather than just factories or real estate. It doesn’t track a specific index, but focuses on finding undervalued businesses in many countries, including Japan, Germany, and the U.S. Well-known holdings include Toyota and L’Oreal. Someone might invest in DTAN for international diversification and the potential growth of companies built on innovation and strong brands. A key risk is that its stock prices can go up and down with global markets and foreign currencies.
How much will it cost me?The Sparkline International Intangible Value ETF (DTAN) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed, focusing on companies with strong intangible assets, which requires more research and expertise.
What would affect this ETF?The Sparkline International Intangible Value ETF (DTAN) could benefit from global economic growth and increased demand for innovative companies leveraging intangible assets, such as intellectual property and brand strength, particularly in sectors like Health Care and Technology. However, it may face challenges from rising interest rates, which can impact the valuation of growth-focused companies, and geopolitical tensions or regulatory changes in the international markets where its top holdings, like Roche and Novartis, operate.
DTAN Top 10 Holdings
DTAN’s story is driven by a trio of big European pharma names: AstraZeneca and Novartis are quietly rising and helping to pull the fund forward, while Roche and Sanofi look more sluggish, acting as a mild brake. On the industrial side, Siemens and Hitachi are steady contributors, but Siemens Energy has been the real spark lately, surging and adding noticeable punch. Shell’s strong run over the past few months also boosts returns. Overall, the ETF leans heavily on non-U.S. health care and industrial champions built on brands, patents, and know-how.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 3.15% | $649.53K | $323.93B | 32.62% | 73 Outperform | |
| Siemens | 3.13% | $645.67K | €201.96B | 23.64% | 74 Outperform | |
| Novartis AG | 2.96% | $609.67K | CHF206.95B | 24.69% | 80 Outperform | |
| L'Oreal | 2.69% | $555.11K | €193.27B | -4.66% | 71 Outperform | |
| Siemens Energy | 2.43% | $501.21K | €151.76B | 141.02% | 72 Outperform | |
| Toyota Motor | 2.41% | $496.76K | ¥37.97T | 7.65% | 80 Outperform | |
| Shell (UK) | 2.33% | $481.48K | £173.22B | 26.24% | 73 Outperform | |
| AstraZeneca | 2.23% | $459.06K | $282.15B | 30.31% | 80 Outperform | |
| Hitachi,Ltd. | 2.16% | $445.98K | ¥22.33T | 20.40% | 77 Outperform | |
| Airbus Group SE | 2.10% | $433.53K | $166.98B | 23.07% | 68 Neutral |
DTAN Technical Analysis
Positive
―
Price Trends
31.12
Positive
31.59
Positive
30.61
Positive
Market Momentum
0.27
Negative
58.78
Neutral
77.96
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DTAN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.85, equal to the 50-day MA of 31.12, and equal to the 200-day MA of 30.61, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 58.78 is Neutral, neither overbought nor oversold. The STOCH value of 77.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DTAN.
DTAN Peer Comparison
Comparison Results
Performance Comparison
DTAN
Sparkline International Intangible Value ETF
32.36
5.07
18.58%
AADR
AdvisorShares Dorsey Wright ADR ETF
―
―
―
ABLG
Abacus Fcf International Leaders Etf
―
―
―
ESIM
Eventide International ETF
―
―
―
VNIE
Vontobel International Equity Active ETF
―
―
―
PZIV
Pzena International Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents